Regenerative Medicine Market in the US 2017-2021

  • ID: 4339941
  • Report
  • Region: United States
  • 107 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • ACE Surgical Supply
  • BioRestorative Therapies
  • Cytori Therapeutics
  • iSTO Biologics
  • NovaRx
  • RhinoCyte
  • MORE
About Regenerative Medicine Market in the US

Regenerative medicine is a bioproduct, which is developed by using translational research techniques such as molecular biology, tissue engineering, and gene engineering. Stem cells and tissue scaffolds have the effective therapeutic potential, which has increased the adoption of regenerative medicine in the US market. Stem cell therapy responds well to various treatments such as dermatological, macular, musculoskeletal, and cardiovascular applications. The regenerative medicine industry includes four key sectors, which help the vendors to develop regenerative medicine.

The analysts forecast the Regenerative Medicine Market in the US to grow at a CAGR of 23.53% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the Regenerative Medicine Market in the US for 2017-2021. To calculate the market size, the report considers the sales, volume, and value of regenerative medicine market in the US.

The report, Regenerative Medicine Market in the US 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Acelity
  • Medtronic
  • MiMedx
  • Organogenesis
  • Zimmer Biomet
Other prominent vendors
  • ACE Surgical Supply
  • Acera Surgical
  • Acologix
  • Advanced Biologics
  • AlloCure
  • AlloSource
  • Alphatec Spine
  • ANTEROGEN
  • Antibe Therapeutics
  • Astellas Pharma
  • Athersys
  • Avita Medical
  • AxoGen
  • Bacterin International
  • Baxter
  • Bellicum Pharmaceuticals
  • BioCardia
  • Biogen
  • BioRestorative Therapies
  • Biostage
  • Bio-Tissue
  • BioTissue
  • bluebird bio
  • BONESUPPORT
  • BrainStorm Cell Therapeutics
  • Caladrius
  • Calimmune
  • Capricor Therapeutics
  • CELGENE
  • Cell Medica
  • Cell Therapy
  • CellBioMed
  • CellSeed
  • Celyad
  • CESCA THERAPEUTICS
  • CTM CRC
  • CryoLife
  • Cynata
  • Cytori Therapeutics
  • Dendreon Pharmaceuticals
  • DiscGenics
  • Fate Therapeutics
  • Fibrocell Science
  • Forticell Bioscience
  • Fortress Biotech
  • FUJIFILM Holdings
  • Gamida Cell
  • Geron
  • GlaxoSmithKline
  • Healthpoint (acquired by Smith & Nephew)
  • Histogen
  • Histogenics
  • Holostem Terapie Avanzate
  • Humacyte
  • Immunocellular Therapeutics
  • Integra LifeSciences
  • Intercytex
  • InVivo Therapeutics
  • iSTO Biologics
  • Janssen Pharmaceuticals
  • Juno Therapeutics
  • Juventas Therapeutics
  • Kiadis Pharma
  • LifeCell
  • LifeNet Health
  • Living Cell Technologies
  • Lonza
  • MaxCyte
  • MEDIPOST
  • Mesoblast
  • Nanofiber Solutions
  • Nanotope
  • Neuralstem
  • NewLink Genetics
  • Northwest Biotherapeutics
  • NovaRx
  • Opexa Therapeutics
  • ORGANOVO HOLDINGS
  • Orteq
  • Orthofix Holdings
  • Osiris Therapeutics
  • Pfizer
  • PHARMICELL
  • Pluristem
  • Prima BioMed
  • Q Therapeutics
  • Regenerex
  • Regenerys
  • Regience
  • Regrow
  • RENOVA THERAPEUTICS
  • RepliCel
  • ReproCELL
  • RhinoCyte
  • Rohto Pharma
  • RTI Surgical
  • SanBio
  • Sangamo Therapeutics
  • Shanghai Sunway Biotech
  • Shire
  • Stratatech
  • SURGILOGIX
  • Synergistic Technologies
  • TAKARA BIO
  • tella
  • Tissue Genesis
  • TissueGene
  • Txcell
  • VentriNova
  • Vericel
  • ViaCyte
  • VistaGen Therapeutics
Market drivers
  • CVD and diabetes in young adult and aging population
  • For a full, detailed list, view the full report
Market challenges
  • High cost of clinical trial
  • For a full, detailed list, view the full report
Market trends
  • Increasing strategic alliances
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the Key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • ACE Surgical Supply
  • BioRestorative Therapies
  • Cytori Therapeutics
  • iSTO Biologics
  • NovaRx
  • RhinoCyte
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Overview of regenerative medicine in the US market
PART 05: Market landscape
  • Market overview
  • Market size and forecast
PART 06: Pipeline portfolio
  • Five forces analysis
PART 07: Market segmentation by product
  • Cell therapy market in US
  • Tissue scaffolds market in US
PART 08: Market segmentation by application
  • Dermatological
  • Musculoskeletal
  • Ocular
  • Cardiovascular
PART 09: Market segmentation by end-user
  • Hospitals
  • ASCs
  • Regenerative medicine centers
PART 10: Decision framework

PART 11: Drivers and challenges
  • Market drivers
  • Market challenges
PART 12: Market trends
  • Increasing strategic alliances
  • Increasing number of regenerative medicine in product line
  • Gene therapy trending toward market expansion
PART 13: Vendor landscape
  • Competitive landscape
PART 14: Key vendor analysis
  • Acelity
  • Medtronic
  • MiMedx Group
  • Organogenesis
  • Zimmer Biomet
  • Other prominent vendors
PART 15: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Overview of key sectors involved in regenerative medicine
Exhibit 02: SBIR and STTR programs
Exhibit 03: Regenerative medicine market in US 2016-2021 ($ billions)
Exhibit 04: Pipeline of regenerative medicines for CVDs
Exhibit 05: Pipeline of regenerative medicines for central nervous system, orthopedic, and ocular disorders
Exhibit 06: Pipeline of regenerative medicines for dermatology and diabetes
Exhibit 07: Pipeline of regenerative medicines for oncology
Exhibit 08: Five forces analysis
Exhibit 09: Regenerative medicine market in US by product
Exhibit 10: Regenerative medicine market in US by product 2016 and 2021 ($ billions)
Exhibit 11: Ethical issues involved in different cell therapy research categories
Exhibit 12: Key cell therapy products marketed in US
Exhibit 13: Cell therapy market in US 2016-2021 ($ billions)
Exhibit 14: Market dynamics: Cell therapy market in US
Exhibit 15: Collaborations for R&D of tissue scaffold
Exhibit 16: Tissue scaffolds market in US 2016-2021 ($ millions)
Exhibit 17: Recent M&A in tissue scaffolds market
Exhibit 18: Market dynamics: Tissue scaffolds market in US
Exhibit 19: Regenerative medicine market in US by application 2016 (%)
Exhibit 20: Market growth: Regenerative medicine market in US by application
Exhibit 21: Overview of dermatological in regenerative medicine market in US
Exhibit 22: Target population and market growth opportunity
Exhibit 23: Pipeline of regenerative medicine for dermatological
Exhibit 24: Overview of musculoskeletal in regenerative medicine market in US
Exhibit 25: Regenerative medicine for occupational injury and sports injury
Exhibit 26: Pipeline of regenerative medicine for musculoskeletal
Exhibit 27: Overview of ocular in regenerative medicine market in US
Exhibit 28: Market overview of CVDs in US
Exhibit 29: Overview of cardiovascular in regenerative medicine market in US
Exhibit 30: Regenerative medicine market in US by end-users 2016
Exhibit 31: Segmentation of hospitals based on number of beds
Exhibit 32: Revenues funded by federal agencies for regenerative medicine research in 2014 ($ millions)
Exhibit 33: Estimated budget of funding for research in regenerative medicines 2012-2017 ($ millions)
Exhibit 34: Regulatory challenges in regenerative product market
Exhibit 35: Major strategic alliances in regenerative medicine market globally
Exhibit 36: Some of the mid and late stage pipeline products for regenerative medicine
Exhibit 37: Competitive structure analysis of regenerative medicine market in US 2016
Exhibit 38: Competitive landscape of regenerative medicine market in US 2016
Exhibit 39: Strategies for large and small companies in regenerative medicine market in US
Exhibit 40: Key recommendations for new entrants in regenerative medicine market in US
Exhibit 41: Acelity: Key highlights
Exhibit 42: Acelity: Strength assessment
Exhibit 43: Acelity: Strategy assessment
Exhibit 44: Acelity: Opportunity assessment
Exhibit 45: Medtronic: Key highlights
Exhibit 46: Medtronic: Strength assessment
Exhibit 47: Medtronic: Strategy assessment
Exhibit 48: Medtronic: Opportunity assessment
Exhibit 49: MiMedx Group: Key highlights
Exhibit 50: MiMedx Group: Strength assessment
Exhibit 51: MiMedx Group: Strategy assessment
Exhibit 52: MiMedx Group: Opportunity assessment
Exhibit 53: Organogenesis: Key highlights
Exhibit 54: Organogenesis: Strength assessment
Exhibit 55: Organogenesis: Strategy assessment
Exhibit 56: Organogenesis: Opportunity assessment
Exhibit 57: Zimmer Biomet: Key highlights
Exhibit 58: Zimmer Biomet: Strength assessment
Exhibit 59: Zimmer Biomet: Strategy assessment
Exhibit 60: Zimmer Biomet: Opportunity assessment
Exhibit 61: Other prominent vendors: Regenerative medicine market in US
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • ACE Surgical Supply
  • BioRestorative Therapies
  • Cytori Therapeutics
  • iSTO Biologics
  • NovaRx
  • RhinoCyte
  • MORE
New Report Released: – Regenerative Medicine Market in the US 2017-2021

The author of the report recognizes the following companies as the key players in the regenerative medicine market in the US: Acelity, Medtronic, MiMedx, Organogenesis, and Zimmer Biomet

Other Prominent Vendors in the market are: ACE Surgical Supply, Acera Surgical, Acologix, Advanced Biologics, AlloCure, AlloSource, Alphatec Spine, ANTEROGEN, Antibe Therapeutics, Astellas Pharma, Athersys, Avita Medical, AxoGen, Bacterin International, Baxter, Bellicum Pharmaceuticals, BioCardia, Biogen, BioRestorative Therapies, Biostage, Bio-Tissue, BioTissue, bluebird bio, BONESUPPORT, BrainStorm Cell Therapeutics, Caladrius, Calimmune, Capricor Therapeutics, CELGENE, Cell Medica, Cell Therapy, CellBioMed, CellSeed, Celyad, CESCA THERAPEUTICS, CTM CRC, CryoLife, Cynata, Cytori Therapeutics, Dendreon Pharmaceuticals, DiscGenics, Fate Therapeutics, Fibrocell Science, Forticell Bioscience, Fortress Biotech, FUJIFILM Holdings, Gamida Cell, Geron, GlaxoSmithKline, Healthpoint, Histogen, Histogenics, Holostem Terapie Avanzate, Humacyte, Immunocellular Therapeutics, Integra LifeSciences, Intercytex, InVivo Therapeutics, iSTO Biologics, Janssen Pharmaceuticals, Juno Therapeutics, Juventas Therapeutics, Kiadis Pharma, LifeCell, LifeNet Health, Living Cell Technologies, Lonza, MaxCyte, MEDIPOST, Mesoblast, Nanofiber Solutions, Nanotope, Neuralstem, NewLink Genetics, Northwest Biotherapeutics, NovaRx, Opexa Therapeutics, ORGANOVO HOLDINGS, Orteq, Orthofix Holdings, Osiris Therapeutics, Pfizer, PHARMICELL, Pluristem, Prima BioMed, Q Therapeutics, Regenerex, Regenerys, Regience, Regrow, RENOVA THERAPEUTICS, RepliCel, ReproCELL, RhinoCyte, Rohto Pharma, RTI Surgical, SanBio, Sangamo Therapeutics, Shanghai Sunway Biotech, Shire, Stratatech, SURGILOGIX, Synergistic Technologies, TAKARA BIO, tella, Tissue Genesis, TissueGene, Txcell, VentriNova, Vericel, ViaCyte, and VistaGen Therapeutics.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is Increasing strategic alliances. Major vendors are entering into strategic alliances with other vendors for drug development and manufacturing. The trend is anticipated during the forecast period. Leading vendors in the market are undertaking M&A to strengthen their global position and to improve their commercial capabilities. Through increasing strategic alliances, many companies are receiving upfront and royalty payment, which encourages many small companies to involve into R&D and develop novel regenerative medicine products.”

According to the report, one of the major drivers for this market is CVD and diabetes in young adult and aging population. CVD is a common disease in the older population; however, it is growing high among young adults owing to lifestyle and over-indulgement in junk foods. A combined study conducted by the Department of Clinical and Experimental Medicine, University of Florence; Department of Health Sciences, University of Milano-Bicocca; and Department of Cardiology, S. Luca Hospital, IRCCS Istituto Auxologico Italiano, Italy in 2015, found that uncontrolled blood pressure increases the risk of CVDs such as stroke and heart attack.

Further, the report states that one of the major factors hindering the growth of this market is High cost of clinical trial. In high-income countries such as the US, the cost of clinical trials and product launch leads the vendors to spend in millions. Most of the small vendors or start-up biotech companies seek government or private funding, but most of the organizations provide the limited amount or grant funding to vendors if the targeted goal is completed. A combined study conducted by John A. Paulson School of Engineering and Applied Sciences, Harvard University and Wyss Institute for Biologically Inspired Engineering at Harvard University, US, in 2015, found that, to receive the FDA approval, pharma and biologics companies, which are into development of regenerative medicine, spend around $802-$2.6 billion for each product approval.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Acelity
  • Medtronic
  • MiMedx
  • Organogenesis
  • Zimmer Biomet
  • ACE Surgical Supply
  • Acera Surgical
  • Acologix
  • Advanced Biologics
  • AlloCure
  • AlloSource
  • Alphatec Spine
  • ANTEROGEN
  • Antibe Therapeutics
  • Astellas Pharma
  • Athersys
  • Avita Medical
  • AxoGen
  • Bacterin International
  • Baxter
  • Bellicum Pharmaceuticals
  • BioCardia
  • Biogen
  • BioRestorative Therapies
  • Biostage
  • Bio-Tissue
  • BioTissue
  • bluebird bio
  • BONESUPPORT
  • BrainStorm Cell Therapeutics
  • Caladrius
  • Calimmune
  • Capricor Therapeutics
  • CELGENE
  • Cell Medica
  • Cell Therapy
  • CellBioMed
  • CellSeed
  • Celyad
  • CESCA THERAPEUTICS
  • CTM CRC
  • CryoLife
  • Cynata
  • Cytori Therapeutics
  • Dendreon Pharmaceuticals
  • DiscGenics
  • Fate Therapeutics
  • Fibrocell Science
  • Forticell Bioscience
  • Fortress Biotech
  • FUJIFILM Holdings
  • Gamida Cell
  • Geron
  • GlaxoSmithKline
  • Healthpoint
  • Histogen
  • Histogenics
  • Holostem Terapie Avanzate
  • Humacyte
  • Immunocellular Therapeutics
  • Integra LifeSciences
  • Intercytex
  • InVivo Therapeutics
  • iSTO Biologics
  • Janssen Pharmaceuticals
  • Juno Therapeutics
  • Juventas Therapeutics
  • Kiadis Pharma
  • LifeCell
  • LifeNet Health
  • Living Cell Technologies
  • Lonza
  • MaxCyte
  • MEDIPOST
  • Mesoblast
  • Nanofiber Solutions
  • Nanotope
  • Neuralstem
  • NewLink Genetics
  • Northwest Biotherapeutics
  • NovaRx
  • Opexa Therapeutics
  • ORGANOVO HOLDINGS
  • Orteq
  • Orthofix Holdings
  • Osiris Therapeutics
  • Pfizer
  • PHARMICELL
  • Pluristem
  • Prima BioMed
  • Q Therapeutics
  • Regenerex
  • Regenerys
  • Regience
  • Regrow
  • RENOVA THERAPEUTICS
  • RepliCel
  • ReproCELL
  • RhinoCyte
  • Rohto Pharma
  • RTI Surgical
  • SanBio
  • Sangamo Therapeutics
  • Shanghai Sunway Biotech
  • Shire
  • Stratatech
  • SURGILOGIX
  • Synergistic Technologies
  • TAKARA BIO
  • tella
  • Tissue Genesis
  • TissueGene
  • Txcell
  • VentriNova
  • Vericel
  • ViaCyte
  • VistaGen Therapeutics
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll